The markets closed modestly higher with the Dow rising 21 points to 17,623 even as sales of existing homes fell 7.1% in February. Nasdaq gained 13 points to 4,808.
On the upside
Shares of Cara Therapeutics (Nasdaq: CARA) continued to climb.
Boeing (NYSE: BA) stock climbed for the eighth day in a row.
The Food and Drug Administration approved Aratana Therapeutics' (Nasdaq: PETX) treatment for osteoarthritis pain and inflammation in dogs.
On the downside
The Wall Street Journal said that BP Prudhoe Bay Royalty Trust (NYSE: BPT) was dying.
Northland Capital downgraded EP Energy (NYSE: EPE) from a Market Perform rating to an Under Perform rating.
MicroVision (Nasdaq: MVIS) will sell common shares through a public offering.
In the broad market, advancing issues barely edged out decliners by a slim margin on the NYSE and by nearly 10 to 9 on Nasdaq. The broader S&P 500 added 2 points to 2,051. Bitcoin slipped $1 to $411.